Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Molecular Microbiology
|
August 1, 1997
The propeptide of Clostridium septicum alpha toxin functions as an intramolecular chaperone and is a potent inhibitor of alpha toxin-dependent cytolysis
B R Sellman, R K Tweten
Science (New York, N.Y.)
|
April 28, 2001
Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax
B R Sellman, M Mourez, R J Collier
The Journal of Biological Chemistry
|
December 13, 2000
Point mutations in anthrax protective antigen that block translocation
B R Sellman, S Nassi, R J Collier
Molecular Microbiology
|
February 1, 1997
Generation of a membrane-bound, oligomerized pre-pore complex is necessary for pore formation by Clostridium septicum alpha toxin
B R Sellman, B L Kagan, R K Tweten
Molecular Microbiology
|
February 27, 1999
Expression and properties of an aerolysin--Clostridium septicum alpha toxin hybrid protein
D B Diep, K L Nelson, T S Lawrence, et al.
The British Journal of Dermatology
|
October 26, 2016
The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies
L Hepburn, D J Hijnen, B R Sellman, et al.
Antimicrobial Agents and Chemotherapy
|
August 29, 2018
Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity <i>In Vitro</i> and Staphylococcus aureus Fitness in Infection Models
C Tkaczyk, E Semenova, Y Y Shi, et al.
Nature Biotechnology
|
October 3, 2001
Designing a polyvalent inhibitor of anthrax toxin
M Mourez, R S Kane, J Mogridge, et al.
Antimicrobial Agents and Chemotherapy
|
May 20, 2015
MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model
L Hua, T S Cohen, Y Shi, et al.
Immuno-Oncology Technology
|
June 27, 2022
Intervention strategies for microbial therapeutics in cancer immunotherapy
V Gopalakrishnan, B Weiner, C B Ford, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Molecular Microbiology
|
August 1, 1997
The propeptide of Clostridium septicum alpha toxin functions as an intramolecular chaperone and is a potent inhibitor of alpha toxin-dependent cytolysis
B R Sellman, R K Tweten
Science (New York, N.Y.)
|
April 28, 2001
Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax
B R Sellman, M Mourez, R J Collier
The Journal of Biological Chemistry
|
December 13, 2000
Point mutations in anthrax protective antigen that block translocation
B R Sellman, S Nassi, R J Collier
Molecular Microbiology
|
February 1, 1997
Generation of a membrane-bound, oligomerized pre-pore complex is necessary for pore formation by Clostridium septicum alpha toxin
B R Sellman, B L Kagan, R K Tweten
Molecular Microbiology
|
February 27, 1999
Expression and properties of an aerolysin--Clostridium septicum alpha toxin hybrid protein
D B Diep, K L Nelson, T S Lawrence, et al.
The British Journal of Dermatology
|
October 26, 2016
The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies
L Hepburn, D J Hijnen, B R Sellman, et al.
Antimicrobial Agents and Chemotherapy
|
August 29, 2018
Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity <i>In Vitro</i> and Staphylococcus aureus Fitness in Infection Models
C Tkaczyk, E Semenova, Y Y Shi, et al.
Nature Biotechnology
|
October 3, 2001
Designing a polyvalent inhibitor of anthrax toxin
M Mourez, R S Kane, J Mogridge, et al.
Antimicrobial Agents and Chemotherapy
|
May 20, 2015
MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model
L Hua, T S Cohen, Y Shi, et al.
Immuno-Oncology Technology
|
June 27, 2022
Intervention strategies for microbial therapeutics in cancer immunotherapy
V Gopalakrishnan, B Weiner, C B Ford, et al.
Page
of 2